Cargando…

66. Improving Antimicrobial Stewardship through Allergy Testing Referrals

BACKGROUND: Penicillins and cephalosporins (PCN/CEPH) are considered first-line antibiotics for numerous infections for their efficacy, tolerability, and cost effectiveness. Unfortunately, their use may be precluded in approximately 10% of the general adult population who self-report ‘allergy’. As a...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Clarissa, Poplin, Victoria, Barry, Brogan, Mason, Mathew J, Gregory, Eric, Clough, Lisa A, Gierer, Selina, Newman, Adelyn R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644354/
http://dx.doi.org/10.1093/ofid/ofab466.268
_version_ 1784610066509332480
author Smith, Clarissa
Poplin, Victoria
Barry, Brogan
Mason, Mathew J
Gregory, Eric
Clough, Lisa A
Gierer, Selina
Newman, Adelyn R
author_facet Smith, Clarissa
Poplin, Victoria
Barry, Brogan
Mason, Mathew J
Gregory, Eric
Clough, Lisa A
Gierer, Selina
Newman, Adelyn R
author_sort Smith, Clarissa
collection PubMed
description BACKGROUND: Penicillins and cephalosporins (PCN/CEPH) are considered first-line antibiotics for numerous infections for their efficacy, tolerability, and cost effectiveness. Unfortunately, their use may be precluded in approximately 10% of the general adult population who self-report ‘allergy’. As a result, suboptimal antimicrobials are substituted which may increase toxicities, length of hospitalizations, and antimicrobial resistance with subsequent expense and morbidity. Multiple organizations endorse beta-lactam allergy skin testing (BLAST) as an essential component of antimicrobial stewardship programs.(.)In an attempt to better describe this patient population as well as to protocolize and improve rates of referral to allergy/immunology clinic, a quality initiative was undertaken at our institution. METHODS: Adult inpatients for whom an infectious disease consult was placed over a 6-month period were chart-reviewed for PCN/CEPH allergy. Inappropriately charted allergies were reconciled and patients were recommended referral to allergy/immunology for formal evaluation with BLAST when appropriate. Referrals were placed for agreeable patients who were then evaluated for appropriateness through history and then scheduled for BLAST. Patients who tolerated oral exposures without adverse effects had the allergy removed from their chart and were educated. RESULTS: 322 patients met inclusion criteria for allergy referral. Of those, 103 agreed to further evaluation, and referrals were placed for 100%. Unfortunately, 7 patients died before referrals could be completed, and 88 referred patients did not complete BLAST for other reasons. In total 8 patients completed BLAST, and allergy was de-labeled in 75% (N= 6) of those cases. CONCLUSION: Our data indicated similar prevalence of reported PCN/CEPH allergy between our institution and the general population. We achieved our aim of improving allergy referral rates among this population, however there was a high rate of attrition in the transitions of care. Qualitative review of selected patients highlights common thematic barriers including the COVID-19 pandemic, fiscal concerns, and acuity of condition. Future directions should include BLAST at the point of care or making referrals from the primary care setting. DISCLOSURES: Lisa A. Clough, MD, Merck (Scientific Research Study Investigator)Merck (Research Grant or Support)ViiV (Scientific Research Study Investigator)
format Online
Article
Text
id pubmed-8644354
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-86443542021-12-06 66. Improving Antimicrobial Stewardship through Allergy Testing Referrals Smith, Clarissa Poplin, Victoria Barry, Brogan Mason, Mathew J Gregory, Eric Clough, Lisa A Gierer, Selina Newman, Adelyn R Open Forum Infect Dis Poster Abstracts BACKGROUND: Penicillins and cephalosporins (PCN/CEPH) are considered first-line antibiotics for numerous infections for their efficacy, tolerability, and cost effectiveness. Unfortunately, their use may be precluded in approximately 10% of the general adult population who self-report ‘allergy’. As a result, suboptimal antimicrobials are substituted which may increase toxicities, length of hospitalizations, and antimicrobial resistance with subsequent expense and morbidity. Multiple organizations endorse beta-lactam allergy skin testing (BLAST) as an essential component of antimicrobial stewardship programs.(.)In an attempt to better describe this patient population as well as to protocolize and improve rates of referral to allergy/immunology clinic, a quality initiative was undertaken at our institution. METHODS: Adult inpatients for whom an infectious disease consult was placed over a 6-month period were chart-reviewed for PCN/CEPH allergy. Inappropriately charted allergies were reconciled and patients were recommended referral to allergy/immunology for formal evaluation with BLAST when appropriate. Referrals were placed for agreeable patients who were then evaluated for appropriateness through history and then scheduled for BLAST. Patients who tolerated oral exposures without adverse effects had the allergy removed from their chart and were educated. RESULTS: 322 patients met inclusion criteria for allergy referral. Of those, 103 agreed to further evaluation, and referrals were placed for 100%. Unfortunately, 7 patients died before referrals could be completed, and 88 referred patients did not complete BLAST for other reasons. In total 8 patients completed BLAST, and allergy was de-labeled in 75% (N= 6) of those cases. CONCLUSION: Our data indicated similar prevalence of reported PCN/CEPH allergy between our institution and the general population. We achieved our aim of improving allergy referral rates among this population, however there was a high rate of attrition in the transitions of care. Qualitative review of selected patients highlights common thematic barriers including the COVID-19 pandemic, fiscal concerns, and acuity of condition. Future directions should include BLAST at the point of care or making referrals from the primary care setting. DISCLOSURES: Lisa A. Clough, MD, Merck (Scientific Research Study Investigator)Merck (Research Grant or Support)ViiV (Scientific Research Study Investigator) Oxford University Press 2021-12-04 /pmc/articles/PMC8644354/ http://dx.doi.org/10.1093/ofid/ofab466.268 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Abstracts
Smith, Clarissa
Poplin, Victoria
Barry, Brogan
Mason, Mathew J
Gregory, Eric
Clough, Lisa A
Gierer, Selina
Newman, Adelyn R
66. Improving Antimicrobial Stewardship through Allergy Testing Referrals
title 66. Improving Antimicrobial Stewardship through Allergy Testing Referrals
title_full 66. Improving Antimicrobial Stewardship through Allergy Testing Referrals
title_fullStr 66. Improving Antimicrobial Stewardship through Allergy Testing Referrals
title_full_unstemmed 66. Improving Antimicrobial Stewardship through Allergy Testing Referrals
title_short 66. Improving Antimicrobial Stewardship through Allergy Testing Referrals
title_sort 66. improving antimicrobial stewardship through allergy testing referrals
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644354/
http://dx.doi.org/10.1093/ofid/ofab466.268
work_keys_str_mv AT smithclarissa 66improvingantimicrobialstewardshipthroughallergytestingreferrals
AT poplinvictoria 66improvingantimicrobialstewardshipthroughallergytestingreferrals
AT barrybrogan 66improvingantimicrobialstewardshipthroughallergytestingreferrals
AT masonmathewj 66improvingantimicrobialstewardshipthroughallergytestingreferrals
AT gregoryeric 66improvingantimicrobialstewardshipthroughallergytestingreferrals
AT cloughlisaa 66improvingantimicrobialstewardshipthroughallergytestingreferrals
AT giererselina 66improvingantimicrobialstewardshipthroughallergytestingreferrals
AT newmanadelynr 66improvingantimicrobialstewardshipthroughallergytestingreferrals